http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1130912-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-93 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J73-00 |
| filingDate | 1965-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29753d06b4fff135099e6d2c14d3e74f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b189b34f400a2e982ed70484413c715 |
| publicationDate | 1968-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1130912-A |
| titleOfInvention | 3-oxa-a-nor-steroids |
| abstract | 1,130,912. 3 - Oxo - A - nor - androstanes. E. R. SQUIBB & SONS Inc. 19 Oct., 1965 No. 44274/65. Heading C2C. The invention comprises 3-oxo-A-nor-5aandrostan- 17#-ol and its esters, 3-oxo-A-nor- 5α-androstan-17-one and 3-oxo-17α-alkyl-A-nor- 5α-androst,an- 17#-ol, and their preparation by (a) reduction of 3-oxo-A-nor-5α-androstan-2 one-17#-ol, or (b) cyclization of 2, 5-seco-3,4- bisnor-androstane-2,5,17#-triol with p-toluene sulphonyl chloride to give the 17α-H-17#-ol of the invention, followed, if desired, by oxidation to the 17-one and treatment of this with a Grignard reagent. The compounds of the invention have anti-androgenic activity. |
| priorityDate | 1965-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7397 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414927286 |
Total number of triples: 16.